So how does this information relate to ozone therapy in animals? When people hear the term ozone, they often think about the ...

Shares of Lululemon Athletica Inc. ( LULU-Q +0.65% ) were higher by 0.9 per cent on Monday after it raised its ...

Poor sleep position is the number one cause of neck- and back-related pain, according to what Ben Gruen, lead chiropractor ...

A new report from Force for Good - "Technology as a Force for Good: Catalyzing New Markets Globally" - highlights technology's potential to catalyze and create new markets, drive sustainable ...

Key Takeaways Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the ...

Ahead of earnings, Jim Patterson wonders if Verizon is a pre-paid, value and premium wireless leader? Can they be everything ...

The global Spatial Genomics & Transcriptomics market is expected to grow to USD 995.7 Million by 2029, up from USD 554.5 ...

Acquisition includes CAPLYTA® (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive and monotherapy; also approved for the treatment of schizo ...

Molecular imaging equipment represents a paradigm shift in diagnostic imaging, offering unparalleled insights into the molecular and cellular processes underlying ... This report offers comprehensive ...

Since the COVID-19 pandemic, mRNA vaccines have been recognized as the most important platform for infectious disease prevention and continue to be utilized across various fields.

J&J will buy all of Intra-Cellular's shares for $132 apiece, representing a 39% premium to their Friday closing price. Shares ...